TELA Insider Trading
Insider Ownership Percentage: 6.00%
Insider Buying (Last 12 Months): $409,995.00
Insider Selling (Last 12 Months): $1,855,836.00
TELA Bio Share Price & Price History
Current Price: $1.24
Price Change: ▼ Price Decrease of -0.135 (-9.85%)
As of 03/28/2025 05:00 PM ET
TELA Bio Insider Trading History
TELA Bio Institutional Trading History
Data available starting January 2016
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Read More on TELA Bio
Volume
222,311 shs
Average Volume
225,807 shs
Market Capitalization
$48.64 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.1
Who are the company insiders with the largest holdings of TELA Bio?
Who are the major institutional investors of TELA Bio?
TELA Bio's top institutional shareholders include:
- Silverarc Capital Management LLC — 7.78%
- AIGH Capital Management LLC — 6.76%
- Stonepine Capital Management LLC — 5.97%
- DAFNA Capital Management LLC — 3.66%
- Royce & Associates LP — 2.54%
- Pentwater Capital Management LP — 2.54%
Learn More about top institutional investors of TELA Bio stock.
Which institutional investors are selling TELA Bio stock?
During the previous quarter, TELA stock was sold by these institutional investors:
- Landscape Capital Management L.L.C.
- Millennium Management LLC
- Bridgeway Capital Management LLC
- Citadel Advisors LLC
Which institutional investors are buying TELA Bio stock?
In the last quarter, TELA stock was bought by institutional investors including:
- Silverarc Capital Management LLC
- DAFNA Capital Management LLC
- Stonepine Capital Management LLC
- Royce & Associates LP
- Perkins Capital Management Inc.
- Pentwater Capital Management LP
- Mink Brook Asset Management LLC
- Renaissance Technologies LLC
In the last year, these company insiders have bought TELA Bio stock:
- Orbimed Advisors Llc (Major Shareholder)
- Antony Koblish (CEO)
- Roberto Cuca (CFO)
- Paul Talmo (CTO)
Learn More investors buying TELA Bio stock.